NOS2 antibody (AA 500-730)
Quick Overview for NOS2 antibody (AA 500-730) (ABIN6144728)
Target
See all NOS2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 500-730
-
Sequence
- VWQDEKRRPK RREIPLKVLV KAVLFACMLM RKTMASRVRV TILFATETGK SEALAWDLGA LFSCAFNPKV VCMDKYRLSC LEEERLLLVV TSTFGNGDCP GNGEKLKKSL FMLKELNNKF RYAVFGLGSS MYPRFCAFAH DIDQKLSHLG ASQLTPMGEG DELSGQEDAF RSWAVQTFKA ACETFDVRGK QHIQIPKLYT SNVTWDPHHY RLVQDSQPLD LSKALSSMHA K
-
Cross-Reactivity
- Human, Mouse
-
Characteristics
- Polyclonal Antibodies
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 500-730 of human NOS2 (NP_000616.3).
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB,1:500 - 1:2000,IHC,1:50 - 1:200,IF,1:50 - 1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- NOS2 (Nitric Oxide Synthase 2, Inducible (NOS2))
-
Alternative Name
- NOS2
-
Background
- Nitric oxide is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. This gene encodes a nitric oxide synthase which is expressed in liver and is inducible by a combination of lipopolysaccharide and certain cytokines. Three related pseudogenes are located within the Smith-Magenis syndrome region on chromosome 17.,NOS,INOS,NOS2A,HEP-NOS,iNOS,NOS2,Cancer,Endocrine & Metabolism,Insulin Receptor Signaling Pathway,Neuroscience,NOS2
-
Molecular Weight
- 126 kDa/131 kDa
-
Gene ID
- 4843
-
UniProt
- P35228
-
Pathways
- Retinoic Acid Receptor Signaling Pathway, Cellular Response to Molecule of Bacterial Origin, Inositol Metabolic Process, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
Target
-